Pasar al contenido principal

HERRAMIENTAS NANOBIOTECNOLOGICAS PARA DETECCION Y TRATAMIENTO DE ENFERMEDADES RARAS: CANCER PANCREATICO, MELANOMA DE UVEA Y DISTROFIA MUSCULAR DE DUCHENNE

PID2020-119352RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION IMDEA NANOCIENCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CASCADE: Naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles

  • López-Valls, María
  • Escalona‐Noguero, Carmen
  • Rodríguez-Díaz, Ciro
  • Pardo, Demian
  • Castellanos, Milagros
  • Milán-Rois, Paula
  • Martínez-Garay, Carlos
  • Coloma, Rocío
  • Abreu, Melanie
  • Cantón, Rafael
  • Galán, Juan Carlos
  • Miranda, Rodolfo
  • Somoza, Álvaro
  • Sot, Begoña
The COVID-19 pandemic has brought to light the need for fast and sensitive detection methods to prevent the spread of pathogens. The scientific community is making a great effort to design new molecular detection methods suitable for fast point-of-care applications. In this regard, a variety of approaches have been developed or optimized, including isothermal amplification of viral nucleic acids, CRISPR-mediated target recognition, and read-out systems based on nanomaterials. Herein, we present CASCADE (CRISPR/CAS-based Colorimetric nucleic Acid DEtection), a sensing system for fast and specific naked-eye detection of SARS-CoV-2 RNA. In this approach, viral RNA is recognized by the LwaCas13a CRISPR protein, which activates its collateral RNase activity. Upon target recognition, Cas13a cleaves ssRNA oligonucleotides conjugated to gold nanoparticles (AuNPs), thus inducing their colloidal aggregation, which can be easily visualized. After an exhaustive optimization of functionalized AuNPs, CASCADE can detect picomolar concentrations of SARS-CoV-2 RNA. This sensitivity is further increased to low femtomolar (3 fM) and even attomolar (40 aM) ranges when CASCADE is coupled to RPA or NASBA isothermal nucleic acid amplification, respectively. We finally demonstrate that CASCADE succeeds in detecting SARS-CoV-2 in clinical samples from nasopharyngeal swabs. In conclusion, CASCADE is a fast and versatile RNA biosensor that can be coupled to different isothermal nucleic acid amplification methods for naked-eye diagnosis of infectious diseases., This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2017-87305-R, PID2020-119352RB-I00), Instituto de Salud Carlos III (FONDO-COVID19:COV20/00144 and COV20/00122) and Madrid Regional Government (NANOCOV-CM and IND2017/IND7809). C.E-N, M. L-V and C.R-D thank Madrid Regional Government for the pre-doctoral Grants (PEJD-2017-PRE/BMD-3730, PEJD-2018-PRE/IND-9584 and PEJD-2017-PRE/IND-4438). P.M.R thanks the Ministry of Economy, Industry and competitiveness of Spain for the FPI fellowship (BES-2017.082521). IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686, CEX2020-001039-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Nanostructured Cu(II) Coordination Polymer Based on Alanine as a Trifunctional Mimic Enzyme and Efficient Composite in the Detection of Sphingobacteria

  • Maldonado, Noelia
  • Latorre, A.
  • Zamora, F.
  • Somoza, Álvaro
  • Gómez-García, C. J.
  • Bastida, Agatha
  • Amo-Ochoa, Pilar
This research raises the potential use of coordination polymers as new useful materials in two essential research fields, allowing the obtaining of a new multiartificial enzyme with the capacity to inhibit the growth of bacteria resistance. The fine selection of the ligands allows the design of a new 2D coordination polymer (CP), with the formula [Cu2(IBA)2(OH2)4]n·6nH2O, by the combination of Cu (II) as the metal center with a pseudoamino acid (H2IBA = isophthaloyl bis β-alanine). Quantitative total X-ray fluorescence (TXRF) analyses show that the obtained CP can gradually release Cu (II) ions. Additionally, this CP can be nanoprocessed and transformed into a metal-organic gel (MOG) by using different Cu (II) salt concentrations and the application of ultrasounds. Considering its nanometric dimensions, the slow Cu (II) release and its simple processability, its performance as an artificial enzyme, and its antibacterial ability were explored. The results obtained show the first nanocoordination polymer acting as an artificial multienzyme (peroxidase, catalase, and superoxodismutase) exhibiting antibacterial activity in the presence of hydrogen peroxide, with selective behavior for three bacterium strains (S. spiritovirum, A. faecales, and B. cereus). Indeed, this CP shows a more robust inhibition capacity for Sphingobacterium. Going beyond that, as there are no comfortable and practically clinical tests capable of detecting the presence of Sphingobacteria, the compound can be easily embedded to form moldable gelatin that will facilitate the handling and low-cost commercial kits., )is work has been partially supported by the Ministerio de Ciencia e Innovación (MICIIN) under the National Program of Sciences and Technological Materials (PID2019- 106383GB-C44) and the Ministerio de Economía y Com- petitividad de España (MINECO) under the National Program of Materials (EI/10.13039/501100011033; PID2019- 108028GB-C22; PID2019- 110632RB-100) and Biomedicine (PID2020-119352RB-I00), the grant CTQ2017-87201-P funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” and the Generalidad Valenciana (Prometeo/2019/076). )is work is dedicated to Khaled Hassanein, Javier Conesa Egea and Verónica García
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale

  • Fernández, Paula
  • Pérez de la Lastra, C.
  • Tosat-Bitrian, Carlota
  • Bueso de Barrio, Jesús Alejandro
  • Thompson, Sebastian
  • Sot, Begoña
  • Salas, Gorka
  • Somoza, Álvaro
  • Espinosa, Ana
  • Castellanos, Milagros
  • Palomo, Valle
49 p.-7 fig.-9 tab., The new and unique possibilities that nanomaterials offer have greatly impacted biomedicine, from the treatment and diagnosis of diseases, to the specific and optimized delivery of therapeutic agents. Technological advances in the synthesis, characterization, standardization, and therapeutic performance of nanoparticles have enabled the approval of several nanomedicines and novel applications. Discoveries continue to rise exponentially in all disease areas, from cancer to neurodegenerative diseases. In Spain, there is a substantial net of researchers involved in the development of nanodiagnostics and nanomedicines. In this review, we summarize the state of the art of nanotechnology, focusing on nanoparticles, for the treatment of diseases in Spain (2017–2022), and give a perspective on the future trends and direction that nanomedicine research is taking., This work has been partially supported by MCIN/AEI /10.13039/501100011033 and European Union NextGenerationEU/PRTR (PID2021-128340OA-I00, PID2020-119352RB-I00, PID2021-127033OB-C21 and RTI2018-101050-J-I00), Comunidad de Madrid (S2022/BMD-7403 RENIM-CM and Talento program 2018-T1/IND-1005), European Union’s Horizon 2020 research and innovation programme (grant agreement No 685795), la Caixa Foundation LCF/PR/HA21/52350003, Asociación Española Contra el Cáncer IDEAS21989THOM, MCIN/AEI/10.13039/501100011033 and “ESF investing in your future” (RYC2019-027489-I, RYC2020-029282-I). CTB thanks Ministerio de Educación (FPU18/06310) for the predoctoral fellowship. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centers of Excellence in R&D (MINECO, CEX2020-001039-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2020-001039-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses

  • Dosil, S. G.
  • Rodríguez-Galán, Ana
  • Fernández-Delgado, Irene
  • Ramírez-Huesca, Marta
  • Milán-Rois, Paula
  • Castellanos, Milagros
  • Somoza, Álvaro
  • Gómez, Manuel José
  • Reyburn, H. T.
  • Valés-Gómez, Mar
  • Sánchez Madrid, Francisco
Natural killer (NK) cells recognize and kill target cells undergoing different types of stress. NK cells are also capable of modulating immune responses. In particular, they regulate T cell functions. Small RNA next-generation sequencing of resting and activated human NK cells and their secreted extracellular vesicles (EVs) led to the identification of a specific repertoire of NK-EV-associated microRNAs and their post-transcriptional modifications signature. Several microRNAs of NK-EVs, namely miR-10b-5p, miR-92a-3p, and miR-155-5p, specifically target molecules involved in Th1 responses. NK-EVs promote the downregulation of GATA3 mRNA in CD4+ T cells and subsequent TBX21 de-repression that leads to Th1 polarization and IFN-γ and IL-2 production. NK-EVs also have an effect on monocyte and moDCs (monocyte-derived dendritic cells) function, driving their activation and increased presentation and costimulatory functions. Nanoparticle-delivered NK-EV microRNAs partially recapitulate NK-EV effects in mice. Our results provide new insights on the immunomodulatory roles of NK-EVs that may help to improve their use as immunotherapeutic tools., This manuscript was funded by grants PDI-2020-120412RB-I00 and PDC2021- 121719-I00 (FS-M) and PID2020-119352RB-I00 (AS) from the Spanish Ministry of Economy and Competitiveness; CAM (S2017/BMD-3671-INFLAMUNE-CM) from the Comunidad de Madrid (FS-M). CIBERCV (CB16/11/00272) and BIOIMID PIE13/041 from the Instituto de Salud Carlos. The current research has received funding from 'la Caixa' Foundation under the project code HR17-00016. Grants from Ramón Areces Foundation 'Ciencias de la Vida y de la Salud' (XIX Concurso-2018) and from Ayuda Fundación BBVA y Equipo de Investigación Científica (BIOMEDICINA-2018) (to FSM). The CNIC is supported by the Ministerio de Ciencia, Innovacion y Universidades and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015–0505). IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, CEX2020-001039-S). SGD is supported by a grant from the Spanish Ministry of Universities. Authors thank Dr Miguel Vicente-Manzanares for critical review and editing. We also thank Dr Francisco Urbano and Dr Covadonga Aguado for their support with EM (TEM facilities, Universidad Autónoma de Madrid), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001039-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Free PCR virus detection via few-layer bismuthene and tetrahedral DNA nanostructured assemblies

  • Gutiérrez-Gálvez, Laura
  • García-Fernández, Daniel
  • Barrio Redondo, Melisa del
  • Luna, Mónica
  • Torres, Íñigo
  • Zamora, Félix
  • Navío, Cristina
  • Milán-Rois, Paula
  • Castellanos, Milagros
  • Abreu, Melanie
  • Cantón, Rafael
  • Galán, Juan Carlos
  • Somoza, Álvaro
  • Miranda, Rodolfo
  • García-Mendiola, Tania
  • Lorenzo, Encarnación
In this work we describe a highly sensitive method based on a biocatalyzed electrochemiluminescence approach. The system combines, for the first time, the use of few-layer bismuthene (FLB) as a platform for the oriented immobilization of tetrahedral DNA nanostructures (TDNs) specifically designed and synthetized to detect a specific SARS-CoV-2 gene sequence. In one of its vertices, these TDNs contain a DNA capture probe of the open reading frame 1 ab (ORF1ab) of the virus, available for the biorecognition of the target DNA/RNA. At the other three vertices, there are thiol groups that enable the stable anchoring/binding to the FLB surface. This novel geometry/approach enables not only the binding of the TDNs to surfaces, but also the orientation of the capture probe in a direction normal to the bismuthine surface so that it is readily accessible for binding/recognition of the specific SARS-CoV-2 sequence. The analytical signal is based on the anodic electrochemiluminescence (ECL) intensity of luminol which, in turn, arises as a result of the reaction with H2O2, generated by the enzymatic reaction of glucose oxidation, catalyzed by the biocatalytic label avidin-glucose oxidase conjugate (Av-GOx), which acts as co-reactant in the electrochemiluminescent reaction. The method exhibits a limit of detection (LOD) of 4.31 aM and a wide linear range from 14.4 aM to 1.00 μM, and its applicability was confirmed by detecting SARS-CoV-2 in nasopharyngeal samples from COVID-19 patients without the need of any amplification process., This work has been financially supported by the Spanish Ministry of Economy and Competitiveness (PID2020-116728RB-I00, PID2020-116661RB-I00, PID2020-119352RB-I00, PDC2021-120782-C21, PID2022-138908NB-C31, CTQ2015-71955-REDT (ELECTROBIONET)) and Community of Madrid (REACT-UE NANOCOV-CM, TRANSNANOAVANSENS, S2018/NMT-4349). We acknowledge the support from the “(MAD2D-CM)-UAM” project funded by Comunidad de Madrid, by the Recovery, Transformation and Resilience Plan, and by NextGenerationEU from the European Union. Laura Gutiérrez-Gálvez was supported by a Formación del Profesorado Universitario (FPU) grant from the Spanish Ministry of Universities (FPU19/06309). Daniel García-Fernández was supported by a Programa Investigo grant from Autonomous Community of Madrid in the framework of the Plan de Recuperación, Transformación y Resiliencia financed by the European Union – NextGenerationEU (09-PIN1-00013.4/2022-Puesto 83). The authors acknowledge the support of the European Union (EU) and Horizon 2020 through Instruct Proposal PID: 21859, and the CRIOMECORR project (ESFRI-2019-01-CSIC-16) to the cryoEM CNB-CSIC facility. We also acknowledge María U. González help with Fluorescence Microscopy and the service from the MiNa Laboratory at IMN, and funding from CM (project S2018/NMT-4291 TEC2SPACE), MINECO (project CSIC13-4E-1794) and EU (FEDER, FSE). IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’Programme for Centres of Excellence in R&D (MINECO, CEX2020-001039-S). Paula Milán-Rois thanks the Spanish Science and Innovation Ministry (BES-2017-082521) for the PhD fellowship. The authors also want to thank Marta Failde, Álvaro Villamayor, and Mario Mencía from the Department of Molecular Biology of UAM for their technical help with DNA analysis., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Detection of the Uveal Melanoma-Associated Mutation GNAQ Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology

  • Escalona-Noguero, Carmen
  • Alarcón-Iniesta, Hernán
  • López-Valls, María
  • Del Carpio, Luis Paul
  • Piulats, Josep Maria
  • Somoza, Álvaro
  • Sot, Begoña
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.3c03460., Uveal melanoma (UM) is a rare ocular tumor characterized by high metastasis risk and poor prognosis. The in-depth characterization of UM's molecular profile is critical for better disease classification and prognosis. Furthermore, the development of detection tools to monitor UM evolution upon treatment is of great interest for designing optimal therapeutic strategies. However, commonly used techniques, such as ddPCR or NGS, are costly, and they involve sophisticated equipment and complex experimental design. The development of alternative sensing methods that are fast, simple, and inexpensive would be of great benefit to improve UM's diagnosis and management, especially when combined with liquid biopsy. Samples from liquid biopsy can be obtained with minimal invasiveness, and the detection of circulating tumor DNA (ctDNA) in UM patients' plasma has proven useful for the diagnosis of metastasis, prognosis prediction, and disease monitoring. In this context, CRISPR/Cas12a-derived molecular sensors, thanks to their high specificity and sensitivity and their potential for point of care diagnosis, are particularly interesting. Here, we developed a CRISPR/Cas12a-based approach for the specific detection of the UM-related mutation GNAQ Q209P that relies on the design of highly specific crRNAs. Coupled with allele-specific PCR, it constitutes a sensitive platform for liquid biopsy detection, capable of sensing GNAQ Q209P in plasma samples with a low ctDNA concentration and fractional abundance. Finally, our method was validated using plasma samples from metastatic UM patients., This work was supported by the Spanish Ministry of Science and Innovation (PID2020-119352RB-I00). C.E.-N. and M.L.-V. thank Madrid Regional Government for the predoctoral Grants (PEJD-2017- PRE/BMD-3730 and PEJD-2018-PRE/IND-9584). L.P.d.C. thanks the Spanish Association Against Cancer (AECC) for the grant “Clínico Junior AECC 2020′′ and the Spanish Society of Medical Oncology (SEOM) for the grant “SEOM-Rio Hortega 2022”. IMDEA Nanociencia acknowledges support from the “Severo Ochoa” Programme for Centres of Excellence Ministerio de Ciencia e Innovación, ref CEX2020-001039-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multifunctional magnetic nanoparticles elicit anti-tumor immunity in a mouse melanoma model

  • Lafuente-Gómez, Nuria
  • de Lázaro, Irene
  • Dhanjani, Mónica
  • García-Soriano, David
  • Sobral, Miguel C.
  • Salas, Gorka
  • Mooney, David J.
  • Somoza, Álvaro
Supplementary data to this article can be found online at https://doi.org/10.1016/j.mtbio.2023.100817, Immunotherapy has emerged as a promising strategy to eradicate cancer cells. Particularly, the development of cancer vaccines to induce a potent and sustained antigen-specific T cell response has become a center of attention. Herein, we describe a novel immunotherapy based on magnetic nanoparticles (MNP) covalently modified with the OVA254-267 antigen and a CpG oligonucleotide via disulfide bonds. The MNP-CpG-COVA significantly enhances dendritic cell activation and CD8+ T cell antitumoral response against B16-OVA melanoma cells in vitro. Notably, the immune response induced by the covalently modified MNP is more potent and sustained over time than that triggered by the free components, highlighting the advantage of nanoformulations in immunotherapies. What is more, the nanoparticles are stable in the blood after in vivo administration and induce potent levels of systemic tumor-specific effector CD8 + T cells. Overall, our findings highlight the potential of covalently functionalized MNP to induce robust immune responses against mouse melanoma., This work was supported by the Spanish Ministry of Economy and Competitiveness [PID2020- 119352RB-I00, PID2019-106301RB-I00], Comunidad de Madrid [IND2017/IND-7809; S2017/BMD-3867, IND2020/IND-17517, S2022/BMD-7403 RENIM-CM], Asociación Española Contra el Cancer, and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [MINECO, Grant SEV-2016-0686, CEX2020-001039-S]. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 685795 (NoCanTher). We also acknowledge the European Structural and Investment Fund. Nuria Lafuente-Gómez also thanks the Spanish Education Ministry [FPU18/02323], the Spanish Ministry of Universities [EST21/00504], and CRIS Cancer Foundation [Outback2022_14, cofinanced by Fundación ADEY] for the funding.Irene de Lázaro was supported by the National Cancer Institute of the National Institutes of Health under award no. U01CA214369. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Consultation and processing of samples for TEM studies were performed at the Electron Microscopy Facility of the Harvard Medical School., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multicore iron oxide nanoparticles for magnetic hyperthermia and combination therapy against cancer cells

  • García-Soriano, David
  • Milán-Rois, Paula
  • Lafuente-Gómez, Nuria
  • Rodríguez-Díaz, Ciro
  • Navío, Cristina
  • Somoza, Álvaro
  • Salas, Gorka
Multicore flower-like iron oxide nanoparticles (IONPs) are among the best candidates for magnetic hyperthermia applications against cancers. However, they are rarely investigated in physiological environments and their efficacy against cancer cells has been even less studied. The combination of magnetic hyperthermia, using multicore IONPs, with selected bioactive molecules should lead to an enhanced activity against cancer cells., This work was supported by the Ministerio de Ciencia e Innovación (PID2019-106301RB-I00 and PID2020-119352RB-I00) and Comunidad de Madrid (S2022/BMD-7403 RENIM-CM). PMR and NLG acknowledge Ministerio de Economía y Competitividad and Ministerio de Ciencia (BES-2017-082521 and FPU18/02323 fellowships). IMDEA Nanociencia acknowledges support from the ’Severo Ochoa’ Programme for Centres of Excellence (Ministerio de Ciencia e Innovación, CEX2020-001039-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Aptamer-conjugated gold nanoparticles enable oligonucleotide delivery into muscle stem cells to promote regeneration of dystrophic muscles

  • Millozzi, Francesco
  • Milán-Rois, Paula
  • Sett, Arghya
  • Delli Carpini, Giovanni
  • De Bardi, Marco
  • Gisbert-Garzarán, Miguel
  • Sandonà, Martina
  • Rodríguez-Díaz, Ciro
  • Martínez-Mingo, Mario
  • Pardo, Irene
  • Esposito, Federica
  • Viscomi, Maria Teresa
  • Bouché, Marina
  • Parolini, Ornella
  • Saccone, Valentina
  • Toulmé, Jean-Jacques
  • Somoza, Álvaro
  • Palacios, Daniela
Inefficient targeting of muscle stem cells (MuSCs), also called satellite cells, represents a major bottleneck of current therapeutic strategies for muscular dystrophies, as it precludes the possibility of promoting compensatory regeneration. Here we describe a muscle-targeting delivery platform, based on gold nanoparticles, that enables the release of therapeutic oligonucleotides into MuSCs. We demonstrate that AuNPs conjugation to an aptamer against α7/β1 integrin dimers directs either local or systemic delivery of microRNA-206 to MuSCs, thereby promoting muscle regeneration and improving muscle functionality, in a mouse model of Duchenne Muscular Dystrophy. We show here that this platform is biocompatible, non-toxic, and non-immunogenic, and it can be easily adapted for the release of a wide range of therapeutic oligonucleotides into diseased muscles., This work was funded by the Eranet-Euronanomed Joint Call 2016 (H2020), project #ER-2016-2360733 to D.P, A.S., and J-J. T and the French Association Against Myopathies, Ignition project #23592 to D.P and A.S. Also, it was partially supported by the Spanish Ministry of Economy and Competitiveness [PID2020-119352RB-I00, PID2023-146982OB-I00], Comunidad de Madrid [S2022/BMD‑7403 RENIM‑CM], Asociación Española Contra el Cáncer (PRYCO223002PEIN), and IMDEA Nanociencia. F.M. acknowledges a PhD fellowship from Università Sapienza, G.D.C. acknowledges a PhD fellowship from Università Cattolica del Sacro Cuore. M.M. acknowledges support from Ministerio de Ciencia e Innovación (FJC2021-048151-I). I.P. acknowledges a PhD fellowship from the Community of Madrid (Grant No: PIPF‑2022SAL‑GL‑24788). IMDEA Nanociencia receives support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MICINN Grant no: CEX2020‑001039‑S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer

  • Lafuente-Gómez, Nuria
  • Martínez-Mingo, Mario
  • Díaz-Riascos, Zamira Vanessa
  • García-Prats, Belén
  • de la Iglesia, Irene
  • Dhanjani, Mónica
  • García-Soriano, David
  • Campos, Luis A
  • Mancilla-Zamora, Sandra
  • Salas, Gorka
  • Abasolo, Ibane
  • Somoza, Álvaro
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jconrel.2025.113791., Pancreatic ductal adenocarcinoma is a highly aggressive cancer with a low survival rate. Thus, efforts are needed to develop more effective treatments. Herein, we propose utilizing magnetic nanoparticles (MNP) for the concurrent delivery of gemcitabine and miRNA34a mimic to target pancreatic cancer cells. The MNP were functionalized with disulfide bonds to selectively release their cargo inside tumor cells. The incorporation of the miRNA34a mimic increased the sensitivity of cells to gemcitabine, especially in BxPC-3 cells. Additionally, the miRNA34a sequence was modified with locked nucleic acids (LNA) to increase stability. The resulting LNA34a showed a stronger cytotoxic effect when combined with gemcitabine, even in PANC-1 cells, which are resistant to the drug. Notably, the modified MNP exhibited less toxicity than their free counterparts when incubated with HaCaT cells, a model of healthy keratinocytes. Additionally, the combined delivery of miRNA34a mimics and gemcitabine using MNP elicited a synergistic cytotoxic effect against pancreatic cancer cells through magnetic hyperthermia. The intratumoral administration of the modified MNP in subcutaneous xenografts of BxPC-3 cells resulted in a sustained increase in temperature when an alternating magnetic field was applied. Notably, the treatment with the MNP functionalized with GEM and LNA34a led to significant changes in the expression of NOTCH1 and NOTCH2 in the tumor, which are direct targets of miRNA34a, as well as HSP70, which is related to the cellular response to stressors like heat., This work was supported by the Spanish Ministry of Economy and Competitiveness [PID2023-146982OB-I00, PID2020- 119352RB-I00, PID2019-106301RB-I00], Comunidad de Madrid [IND2017/IND-7809; S2017/BMD-3867, IND2020/IND-17517, S2022/BMD-7403 RENIM-CM], Asociación Española Contra el Cáncer [PRYCO223002PEIN], and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [MINECO, Grant SEV-2016-0686, CEX2020-001039-S]. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 685795 (NoCanTher) and No 814607 (Safe-n-Medtech). We also acknowledge the European Structural and Investment Fund. Nuria Lafuente-Gómez and Mario Martínez-Mingo thankSpanish Science Ministry [FPU18/02323, FJC2021-048151-I, respectively] for the funding., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tri-Modal Anticancer Strategies with Doxorubicin-Loaded Iron Oxide Nanoparticles Integrating Chemo and Magneto-Photothermal Therapeutic Effects

  • López-Méndez, Rosalía
  • Lafuente-Gómez, Nuria
  • Céspedes, Eva
  • Dhanjani, Mónica
  • París-Ogáyar, Marina
  • Terán, Francisco José
  • Serrano, Aida
  • Camarero, Julio
  • Salas, Gorka
  • Wilhelm, Claire
  • Somoza, Álvaro
  • Espinosa, Ana
In this study, the potential of maghemite (γ-Fe<inf>2</inf>O<inf>3</inf>) nanoparticles (MNPs) functionalized with doxorubicin (DOX) is explored for chemo-magneto-photothermal therapy in cancer treatment. MNPs are functionalized through electrostatic interactions or disulfide bonds, achieving high drug-loading efficiencies. The trimodal approach combines magnetic hyperthermia (MHT), photothermal therapy (PTT) and local chemotherapy, utilizing low and clinically relevant doses. Thermal treatments induced controlled temperature increases, triggering pH-sensitive DOX release in the acidic environments typical of tumors. Efficient uptake of DOX-loaded MNPs is observed, and their structural integrity is confirmed using advanced synchrotron spectroscopic techniques. Cytotoxicity assays show that MHT and PTT together enhanced therapeutic efficacy compared to free DOX, while minimizing toxicity to healthy cells. This study demonstrates that combining thermal therapies with controlled drug release provides a promising strategy for improving cancer treatment outcomes. The findings highlight the potential clinical application of multifunctional nanoparticle systems for targeted, low-toxicity cancer therapies, advancing the path toward more effective and accessible treatments., This work was funded by MCIN/AEI/10.13039/501100011033 (PID2021-127033OB-C21, PID2020-119352RB-I00, PID2020-117080RB-C53, PID2023-146982OB-I00, PID2023-152944OB-I00, PID2024-161273OB-C21), MCIN/AEI/10.13039/501100011033 and the “European Union NextGenerationEU/PRTR" (CNS2023-144689), CSIC (PIE-20226AT024 and Ayudas Incorporación de Científicos Titulares OEP (ref. 2024ICT15)) and Comunidad de Madrid (2018-T1/IND-1005, ASAP-CM S2022/BMD-7434, S2022/BMD-7403 RENIM-CM and TEC-2024/TEC-380 “Mag4TIC”). IMDEA Nanociencia acknowledges support from the Severo Ochoa program for Centers of Excellence in R&D (CEX2020-001039-S) and FPI grant PRE2020-96246 (R.L.-M.). N.L.-G. also thanks the Spanish Science Ministry (FPU18/02323) for the funding. A.S. acknowledges financial support from grant RYC2021–031236-I funded by MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”. M.P.O. acknowledges the financial support from MICINN for an FPU (FPU20/03166). This work has been funded with €1.026 million by the Comunidad de Madrid through the LUNABRAIN-CM R&D activities program (TEC-2024/TEC-43), granted by Order 5696/2024. This work was supported by the Severo Ochoa Program for Centers of Excellence in R&D (CEX2024-001445-S), granted to the Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC)., Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares